Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | CDK4 | P11802 | 8/20 | 0.47 |
| ▸ | CCND1 | P24385 | 8/20 | 0.47 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.47 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.47 |
| ▸ | CDK1 | P06493 | 2/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.47 |
| ▸ | CDK2 | P24941 | 2/20 | 0.47 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | CLK1 | P49759 | 1/20 | 0.44 |
| ▸ | CDK9 | P50750 | 1/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30282028 | 1.00 | DYRK1A (0.61) | DYRK1ACYP2A6CYP1A2ARCDK4 | |
| SCHEMBL12219437 | 0.83 | KIF11 (0.57) | CYP2A6CDK4CCND1CCNB2CCNE2 | |
| SCHEMBL30280567 | 0.82 | CYP2A6 (0.52) | DYRK1ACYP2A6CYP1A2CDK4CCND1 | |
| SCHEMBL30914258 | 0.82 | KIF11 (0.66) | CYP2A6CDK4CCND1CCNB2CCNE2 | |
| SCHEMBL6523866 | 0.82 | KIF11 (0.66) | CYP2A6CDK4CCND1CCNB2CCNE2 | |
| SCHEMBL30730994 | 0.82 | KIF11 (0.66) | CYP2A6CDK4CCND1CCNB2CCNE2 | |
| SCHEMBL22839599 | 0.81 | KIF11 (0.61) | DYRK1ACYP2A6CYP1A2ARCDK4 | |
| SCHEMBL23702735 | 0.79 | CDK4 (0.47) | DYRK1ACDK4CCND1CCNB2CCNE2 | |
| SCHEMBL17722737 | 0.79 | CDK4 (0.49) | DYRK1ACDK4CCND1CCNB2CCNE2 | |
| SCHEMBL24561610 | 0.79 | CDK4 (0.47) | DYRK1ACYP2A6CYP1A2ARCDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137925-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230137925-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4168417-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | Idemitsu Kosan Co., Ltd (JP) | 2023-04-26 | — | — | EP | disclosed |
| CN-115715293-A | Heterocyclic compound and organic electroluminescent device comprising the same | 出光兴产株式会社 | 2023-02-24 | — | — | CN | disclosed |
| US-20220020932-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-01-20 | — | — | US | disclosed |
| WO-2021255698-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2021-12-23 | — | — | WO | disclosed |
| WO-2021255698-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2021-12-23 | — | — | WO | disclosed |
| WO-2020101169-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220020932-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, OR51E2, OR10J3 | DYRK1A 4439/4885CYP2A6 1577/4885CYP1A2 901/4885 |
| US-20230137925-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | DDT, DDC, ODC1 | DYRK1A 4330/4885CYP2A6 1956/4885CYP1A2 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.